Glenmark Reaps Favipiravir Gains, Progresses COVID-19 Nasal Spray

Emergency India Go-Ahead For NO Spray?

accelerate
Sharp gains on home market for Glenmark in Q1 • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip